Literature DB >> 32381312

Managing Severely Malunited Calcaneal Fractures and Fracture-Dislocations.

Stefan Rammelt1, Christine Marx2.   

Abstract

Severe calcaneal malunions are debilitating conditions owing to substantial hindfoot deformity with subtalar arthritis and soft tissue imbalance. Type III malunions are best treated with a subtalar distraction bone block fusion. Additional osteotomies may be required for severe varus or superior displacement of the calcaneal tuberosity. Type IV malunions result from malunited calcaneal fracture-dislocations and require a 3-dimensional corrective osteotomy. Type V malunions warrant additional ankle debridement and reconstruction of the calcaneal shape to provide support for the talus in the ankle mortise. Accompanying soft tissue procedures include Achilles tendon lengthening, peroneal tendon release, and rerouting behind the lateral malleolus.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankle impingement; Calcaneus; Fusion; Malunion; Necrosis; Nonunion; Osteotomy; Peroneal tendon dislocation

Mesh:

Year:  2020        PMID: 32381312     DOI: 10.1016/j.fcl.2020.02.005

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  3 in total

1.  Staged Ilizarov distraction histogenesis and corrective reconstruction for severe malunited calcaneal fractures.

Authors:  Ting-Jiang Gan; Ya-Xing Li; Xi Liu; Yu Chen; Jia Li; Hui Zhang
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-06       Impact factor: 3.067

2.  Treatment of Fracture of the Calcaneus via Bone Axial X-Ray Image-Based Minimally Invasive Approach.

Authors:  Jie Xiao; Zengfeng Xin; Xiaojun Fu; Jiaqi Huang; Bi Zhang; Haiping Yu
Journal:  Comput Math Methods Med       Date:  2022-07-01       Impact factor: 2.809

Review 3.  Malunited calcaneal fracture: the role and technique of osteotomy-a systematic review.

Authors:  Xin Guan; Dayong Xiang; Yanjun Hu; Guiyong Jiang; Bin Yu; Bowei Wang
Journal:  Int Orthop       Date:  2021-07-09       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.